Gilead unit Kite Pharma to lay off 300 workers; impact on former Tmunity operations in Philadelphia not disclosed

Kite Pharma established operations at B+labs in the Cira Centre after acquiring Penn spinout Tmunity Therapeutics in February.

Previous Los Angeles investors sell Valpak to New York holding company
Next AbbVie to spend $10.1B to acquire ImmunoGen